A citation-based method for searching scientific literature

Tiantian Liu, Jiansheng Wang, Yuchen Xiu, Yujiao Wu, Dawei Xu. Cancers (Basel) 2021
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Telomeres and telomerase: three decades of progress.
Jerry W Shay, Woodring E Wright. Nat Rev Genet 2019
297
33

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
33



GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.
Xiaotian Yuan, Ninni Mu, Na Wang, Klas Strååt, Anastasios Sofiadis, Yanxia Guo, Adam Stenman, Kailin Li, Guanghui Cheng, Lu Zhang,[...]. Oncogene 2019
30
33


GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.
Yanxia Guo, Xiaotian Yuan, Kailin Li, Mingkai Dai, Lu Zhang, Yujiao Wu, Chao Sun, Yuan Chen, Guanghui Cheng, Cheng Liu,[...]. Cell Death Differ 2020
21
33

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
33

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
171
33

Coexistence of TERT promoter and BRAF mutations in papillary thyroid carcinoma: added value in patient prognosis?
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Manuel Sobrinho-Simões, Paula Soares. J Clin Oncol 2015
29
33

Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Robert J A Bell, H Tomas Rube, Alex Kreig, Andrew Mancini, Shaun D Fouse, Raman P Nagarajan, Serah Choi, Chibo Hong, Daniel He, Melike Pekmezci,[...]. Science 2015
346
33

GA-binding protein transcription factor: a review of GABP as an integrator of intracellular signaling and protein-protein interactions.
Alan G Rosmarin, Karen K Resendes, Zhongfa Yang, John N McMillan, Shawna L Fleming. Blood Cells Mol Dis 2004
153
33

Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner.
Andrew Mancini, Ana Xavier-Magalhães, Wendy S Woods, Kien-Thiet Nguyen, Alexandra M Amen, Josie L Hayes, Christof Fellmann, Michael Gapinske, Andrew M McKinney, Chibo Hong,[...]. Cancer Cell 2018
69
33

Stages of embryonic development of the zebrafish.
C B Kimmel, W W Ballard, S R Kimmel, B Ullmann, T F Schilling. Dev Dyn 1995
33

Telomerase at the intersection of cancer and aging.
Bruno Bernardes de Jesus, Maria A Blasco. Trends Genet 2013
127
33

Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis.
Pan Du, Xiao Zhang, Chiang-Ching Huang, Nadereh Jafari, Warren A Kibbe, Lifang Hou, Simon M Lin. BMC Bioinformatics 2010
33

Generation of orientation tools for automated zebrafish screening assays using desktop 3D printing.
Jonas N Wittbrodt, Urban Liebel, Jochen Gehrig. BMC Biotechnol 2014
42
33

DNA methylation data analysis and its application to cancer research.
Xiaotu Ma, Yi-Wei Wang, Michael Q Zhang, Adi F Gazdar. Epigenomics 2013
66
33

Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2.
Rengyun Liu, Jie Tan, Xiaopei Shen, Ke Jiang, Chaoqun Wang, Guangwu Zhu, Mingzhao Xing. Proc Natl Acad Sci U S A 2021
7
33

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
102
33

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
433
33

Therapeutic strategies for targeting telomerase in cancer.
Xing Chen, Wen-Jian Tang, Jing Bo Shi, Ming Ming Liu, Xin-Hua Liu. Med Res Rev 2020
24
33


Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Young Shin Song, Seong-Keun Yoo, Hwan Hee Kim, Gyeongseo Jung, Ah-Reum Oh, Ji-Young Cha, Su-Jin Kim, Sun Wook Cho, Kyu Eun Lee, Jeong-Sun Seo,[...]. Endocr Relat Cancer 2019
34
33

ETS Factor ETV5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid Cancer.
Martyn Bullock, Grace Lim, Ying Zhu, Helena Åberg, Sergey Kurdyukov, Roderick Clifton-Bligh. Thyroid 2019
18
33

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
33

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.
Iñigo Landa, Ian Ganly, Timothy A Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A Ghossein, James A Fagin. J Clin Endocrinol Metab 2013
283
33

Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Mohammad A Jafri, Shakeel A Ansari, Mohammed H Alqahtani, Jerry W Shay. Genome Med 2016
302
33

Development and characterization of six new human papillary thyroid carcinoma cell lines.
Ying C Henderson, Soon-Hyun Ahn, Junsun Ryu, Yunyun Chen, Michelle D Williams, Adel K El-Naggar, Mihai Gagea, Rebecca E Schweppe, Bryan R Haugen, Stephen Y Lai,[...]. J Clin Endocrinol Metab 2015
17
33

Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Josh Lewis Stern, Dan Theodorescu, Bert Vogelstein, Nickolas Papadopoulos, Thomas R Cech. Genes Dev 2015
131
33

GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours.
Johan O Paulsson, Na Wang, Jiwei Gao, Adam Stenman, Jan Zedenius, Ninni Mu, Weng-Onn Lui, Catharina Larsson, C Christofer Juhlin. Endocr Relat Cancer 2020
16
33

TERT promoter mutations in thyroid cancer.
Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2016
206
33

Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases.
Bin Xu, Talia Fuchs, Snjezana Dogan, Iñigo Landa, Nora Katabi, James A Fagin, R Michael Tuttle, Eric Sherman, Anthony J Gill, Ronald Ghossein. Thyroid 2020
64
33

Targeting tetramer-forming GABPβ isoforms impairs self-renewal of hematopoietic and leukemic stem cells.
Shuyang Yu, Xuefang Jing, John D Colgan, Dong-Mei Zhao, Hai-Hui Xue. Cell Stem Cell 2012
24
33

Multiple ETS Factors Participate in the Transcriptional Control of TERT Mutant Promoter in Thyroid Cancers.
Caitlin E M Thornton, Jingzhu Hao, Prasanna P Tamarapu, Iñigo Landa. Cancers (Basel) 2022
2
50

Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas.
Meihua Jin, Dong Eun Song, Jonghwa Ahn, Eyun Song, Yu-Mi Lee, Tae-Yon Sung, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Min Ji Jeon,[...]. Cancers (Basel) 2021
6
33

RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient.
Rozita Bagheri-Yarmand, Naifa L Busaidy, Elena McBeath, Brian P Danysh, Kurt W Evans, Tyler J Moss, Argun Akcakanat, Patrick K S Ng, Christina M Knippler, Jalyn A Golden,[...]. Cancers (Basel) 2021
4
33

Development of Novel Follicular Thyroid Cancer Models Which Progress to Poorly Differentiated and Anaplastic Thyroid Cancer.
Caitlin O Caperton, Lee Ann Jolly, Nicole Massoll, Andrew J Bauer, Aime T Franco. Cancers (Basel) 2021
2
50

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Rui Batista, Joana Peixoto, Catarina Tavares, Ricardo Celestino, Ana Almeida, Catarina Salgado, Catarina Eloy,[...]. J Clin Endocrinol Metab 2014
338
33

Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We?
Cesar Seigi Fuziwara, Diego Claro de Mello, Edna Teruko Kimura. Cancers (Basel) 2022
1
100

Secreted Factors by Anaplastic Thyroid Cancer Cells Induce Tumor-Promoting M2-like Macrophage Polarization through a TIM3-Dependent Mechanism.
Cinthia Carolina Stempin, Romina Celeste Geysels, Sunmi Park, Luz Maria Palacios, Ximena Volpini, Claudia Cristina Motran, Eva Virginia Acosta Rodríguez, Juan Pablo Nicola, Sheue-Yann Cheng, Claudia Gabriela Pellizas,[...]. Cancers (Basel) 2021
6
33

APOBEC SBS13 Mutational Signature-A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma.
Sarah Siraj, Tariq Masoodi, Abdul K Siraj, Saud Azam, Zeeshan Qadri, Sandeep K Parvathareddy, Rong Bu, Khawar S Siddiqui, Saif S Al-Sobhi, Mohammed AlDawish,[...]. Cancers (Basel) 2022
2
50

MiRNA Deregulation Distinguishes Anaplastic Thyroid Carcinoma (ATC) and Supports Upregulation of Oncogene Expression.
Danny Misiak, Marcus Bauer, Jana Lange, Jacob Haase, Juliane Braun, Kerstin Lorenz, Claudia Wickenhauser, Stefan Hüttelmaier. Cancers (Basel) 2021
2
50



Differentiated Thyroid Cancer with Biochemical Incomplete Response: Clinico-Pathological Characteristics and Long Term Disease Outcomes.
Miriam Steinschneider, Jacob Pitaro, Shlomit Koren, Yuval Mizrakli, Carlos Benbassat, Limor Muallem Kalmovich. Cancers (Basel) 2021
4
33

Medullary Thyroid Carcinoma Mutational Spectrum Update and Signaling-Type Inference by Transcriptional Profiles: Literature Meta-Analysis and Study of Tumor Samples.
Emanuela Minna, Paola Romeo, Matteo Dugo, Loris De Cecco, Antonella Aiello, Federico Pistore, Andrea Carenzo, Angela Greco, Maria Grazia Borrello. Cancers (Basel) 2022
2
50

Biologic and Clinical Perspectives on Thyroid Cancer.
James A Fagin, Samuel A Wells. N Engl J Med 2016
431
33

Radio-Iodide Treatment: From Molecular Aspects to the Clinical View.
Antonio De la Vieja, Garcilaso Riesco-Eizaguirre. Cancers (Basel) 2021
11
33

Annual Hazard Rate of Recurrence in Middle Eastern Papillary Thyroid Cancer over a Long-Term Follow-Up.
Abdul K Siraj, Sandeep Kumar Parvathareddy, Zeeshan Qadri, Khawar Siddiqui, Saif S Al-Sobhi, Fouad Al-Dayel, Khawla S Al-Kuraya. Cancers (Basel) 2020
9
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.